Drug Type Recombinant protein |
Synonyms long-acting GM-CSF (Bolder BioTechnology) |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Radiation Syndrome | Preclinical | United States | 01 Dec 2024 | |
Neutropenia | Preclinical | United States | - |